Cortisone – Cortisonum Aceticum

The attenuations are prepared from Cortisone-21-acetate (17a,21-Dihydroxy-4- pregnene-3,11,20-trione-21-acetate) C₂₃H₃₀O₆, MW: 402.5 (Potentised allopathic compound).

The main indications are:

Damage to adrenal cortex, pituitary and connective tissue. Congenital adrenal hy- perplasia. Simmonds’ disease. Consequences of abuse of cortisone, and other iatro- genic damage. May also be tried in osteochondritis, weakness of joints (giving way), osteoporosis, Sudeck’s atrophy and others, and diseases being manifested in the con- nective tissue. May profitably be combined with Funiculus Umbilicalis and Silicea. The German Monograph-Preparation Commission for the Homoeopathic Field of Therapy has, under the Preparation Monograph for Cortisonum, published the fol- lowing indication(s) in the German Bundesanzeiger (German Federal Gazette) for cortisone: inflammations of the mucosae of the eye and of the respiratory organs; asthma; inflammation, ulceration, and bleeding of the mucosa of the alimentary tract; bone decalcification; disorders of the skin, blood, and vascular systems; be-

havioural disorders and emotional discord or upset.